Literature DB >> 8527890

Epithelial-mesenchymal transitions in development and tumor progression.

W Birchmeier1, C Birchmeier.   

Abstract

Epithelial-mesenchymal transitions play important roles in development and malignancy. Here we discuss molecular events in the control of such transitions: changes in cellular adhesion components, action of oncogenes and tyrosine kinase receptors, as well as activation of transcription factors. In development, epithelial-mesenchymal transitions take place in a temporally and spatially controlled manner, whereas in tumors these changes are highly uncontrolled. Loss of epithelial character is typically observed late in progression of human carcinomas, and correlates there with the acquisition of invasive and metastatic potential.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8527890     DOI: 10.1007/978-3-0348-9070-0_1

Source DB:  PubMed          Journal:  EXS        ISSN: 1023-294X


  23 in total

Review 1.  Transforming growth factor-beta, basement membrane, and epithelial-mesenchymal transdifferentiation: implications for fibrosis in kidney disease.

Authors:  P J Stahl; D Felsen
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

Review 2.  Signal transduction in cancer.

Authors:  Richard Sever; Joan S Brugge
Journal:  Cold Spring Harb Perspect Med       Date:  2015-04-01       Impact factor: 6.915

Review 3.  Embryonic reversions and lineage infidelities in tumour cells: genome-based models and role of genetic instability.

Authors:  Leon P Bignold
Journal:  Int J Exp Pathol       Date:  2005-04       Impact factor: 1.925

4.  Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation.

Authors:  Simona Parrinello; Jean-Philippe Coppe; Ana Krtolica; Judith Campisi
Journal:  J Cell Sci       Date:  2005-01-18       Impact factor: 5.285

5.  c-MET expression in myofibroblasts: role in autocrine activation and prognostic significance in lung adenocarcinoma.

Authors:  M Tokunou; T Niki; K Eguchi; S Iba; H Tsuda; T Yamada; Y Matsuno; H Kondo; Y Saitoh; H Imamura; S Hirohashi
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

6.  EGR-1 plays a protective role in AMPK inhibitor compound C-induced apoptosis through ROS-induced ERK activation in skin cancer cells.

Authors:  Kai-Cheng Chuang; Fan-Wen Chen; Meng-Hsiun Tsai; Jeng-Jer Shieh
Journal:  Oncol Lett       Date:  2021-02-19       Impact factor: 2.967

7.  MiR-214 inhibits cell migration, invasion and promotes the drug sensitivity in human cervical cancer by targeting FOXM1.

Authors:  Jian-Mei Wang; Bao-Hui Ju; Cai-Jun Pan; Yan Gu; Meng-Qi Li; Li Sun; Yan-Ying Xu; Li-Rong Yin
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

8.  Bmi-1 regulates epithelial-to-mesenchymal transition to promote migration and invasion of breast cancer cells.

Authors:  Haiyu Li; Fangzhou Song; Xingfeng Chen; Yun Li; Jianjun Fan; Xiangmei Wu
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

9.  Renal fibrosis. Extracellular matrix microenvironment regulates migratory behavior of activated tubular epithelial cells.

Authors:  Michael Zeisberg; Yohei Maeshima; Barbara Mosterman; Raghu Kalluri
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

10.  Converging signals synergistically activate the LAMC2 promoter and lead to accumulation of the laminin gamma 2 chain in human colon carcinoma cells.

Authors:  Jørgen Olsen; Lene T Kirkeby; Marianne M Brorsson; Sally Dabelsteen; Jesper T Troelsen; Randi Bordoy; Kirsten Fenger; Lars-Inge Larsson; Patricia Simon-Assmann
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.